CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		152,135,026
Beginning balance at Dec. 31, 2022	$ 77,505	$ 1	$ 325,431	$ (247,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued upon vesting of restricted share units, net of withholding (in shares)		297,888
Common shares issued upon vesting of restricted share units, net of withholding	(69)		(69)
Share-based compensation	375		375
Net loss	(2,912)			(2,912)
Ending balance (in shares) at Mar. 31, 2023		152,432,914
Ending balance at Mar. 31, 2023	74,899	$ 1	325,737	(250,839)
Beginning balance (in shares) at Dec. 31, 2023		154,332,366
Beginning balance at Dec. 31, 2023	55,558	$ 1	327,280	(271,723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued upon vesting of restricted share units, net of withholding (in shares)		2,895,489
Common shares issued upon vesting of restricted share units, net of withholding	(98)		(98)
Share-based compensation	842		842
Net loss	(9,634)			(9,634)
Ending balance (in shares) at Mar. 31, 2024		157,227,855
Ending balance at Mar. 31, 2024	$ 46,668	$ 1	$ 328,024	$ (281,357)